A Novel Simple Method to Purify Recombinant Soluble Human Complement Receptor Type 1 (sCR 1) from CHO Cell Culture
![]() |
Wang, Pi-Chao
(Institute of Applied Biochemistry, Tsukuba University)
Hisamune Kato (Institute of Applied Biochemistry, Tsukuba University) Takehiro Inoue (Institute of Applied Biochemistry, Tsukuba University) Masatoshi Matsumura (Institute of Applied Biochemistry, Tsukuba University) Noriyuki Ishii (Biological Information Research Center, National Institute of Advanced Industrial Science and Technology) Yoshinobu Murakami (Institute for Frontier Medical Science Kyoto University) Tsukasa Seya (Department of immunology, Osaka Medical Center fro Cancer and Cardiovascular Disease) |
1 |
Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats
/
DOI ScienceOn |
2 |
Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass
/
DOI ScienceOn |
3 |
Preparative two-step purification of recombinant human basic fibroblast growth factor from high-cell-density cultivation of Escherichia coli
/
DOI |
4 |
Rapid purification of human complement receptor type 1 (CD35, CR1)
/
DOI ScienceOn |
5 |
Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass
/
DOI ScienceOn |
6 |
Purification of human von Willebrand factorcleaving protease and its identification as a new member of the metalloproteinase family
/
DOI ScienceOn |
7 |
Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis
/
DOI ScienceOn |
8 |
Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function
/
|
9 |
Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT
/
DOI |
10 |
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflam-mation and necrosis
/
DOI |
11 |
Heparan sulfate is required for interaction and activation of the epithelial cell fibroblast growth factor receptor-2Ⅲb with stromal-derived fibroblast growth factor-7
/
DOI ScienceOn |
12 |
Direct refolding of recombinant human growth differntiation factor 5 for large-scale production process
/
DOI ScienceOn |
13 |
Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele
/
|
14 |
Effect of cell surface concentration of human DAF on transgenic pig aortic endothelial cells on the degree of protection afforded against human complement deposition
/
DOI ScienceOn |
15 |
Complement dependent clearance of apoptotic cells by human macrophages
/
DOI ScienceOn |
16 |
Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase
/
|
17 |
Murine C4-binding protein: a rapid purification method by affinity chromatography
/
|
18 |
Effects of thrombospondin purified by heparin affinity or ion-exchange chromatography on the alternative complement pathway
/
DOI ScienceOn |
19 |
Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury
/
|
20 |
Factor H co-purifies with thrombospondin isolated from platelet secretate
/
DOI ScienceOn |
21 |
Factor J: Isolation and characterization of a new polypeptide inhibitor of complement C1
/
|
22 |
The effect of soluble complement receptor type 1 on hyper-acute rejection of porcine xenografts
/
DOI ScienceOn |
23 |
Heparan Sulfate Proteoglycans of the Cardiovascular System
/
DOI ScienceOn |
24 |
Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1
/
DOI ScienceOn |
25 |
A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway
/
DOI ScienceOn |
26 |
Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins
/
DOI ScienceOn |
27 |
Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats
/
|
28 |
Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP
/
DOI ScienceOn |
29 |
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18)
/
DOI ScienceOn |
30 |
Factor H co-purifies with thrombospondin isolated from platelet secretate
/
DOI ScienceOn |
31 |
Primary sequence of an alternatively spliced form of CR1. Candidate for the 75.000 M(r) complement receptor expressed on chimpanzee erythrocytes
/
|
32 |
Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion molecules
/
DOI ScienceOn |
33 |
Mapping epitopes for 20 monoclonal antibodies to CR1
/
DOI |
34 |
Improved preparation and crystallization of 25 kDa human fibroblast growth factor-9
/
DOI ScienceOn |
35 |
Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis
/
DOI ScienceOn |
36 |
Regulatory system of guinea-pig complement C3b: tests for compatibility of guinea-pig factors H and I with human factors
/
DOI ScienceOn |
37 |
Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1)
/
DOI ScienceOn |
38 |
C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae
/
DOI ScienceOn |
39 |
Activation of the alternative pathway of complement by a phos-phorothioate oligonucleotide: potential mechanism of action
/
|
40 |
Cultivation of mammalian cells in serum-free media
/
|
41 |
Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor(DAF)
/
|
42 |
Active form of human hepatocyte growth factor is excreted into bile after hepatobiliary resection
/
DOI ScienceOn |
43 |
Prevention of hyperacute rejection by phosphatidylinositol- anchored mini-complement receptor type 1
/
DOI ScienceOn |
44 |
Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3"
/
|
45 |
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
/
DOI ScienceOn |
46 |
Protective effects of soluble CR1 in complement and neutrophil-mediated tissue injury
/
|
47 |
C3a and C5a anaphylatoxins bind to heparin-based sorbent in low density lipoprotein apheresis: in vitro and in vivo investigations
/
DOI ScienceOn |
![]() |